T
his article describes the results of a study in which the Australasian Cryptococcal Surveillance Register (ACSR) was compared with the NSW AIDS Register (NSWAR) to determine whether linking these databases could improve AIDS surveillance, Surveillance of AIDS in Australia relies primarily on the passive receipt of notifications from doctors in each State and Territory1, supplemented by active surveillance carried out on an annual basis. AIDS is notiflable by medical practitioners in NSW under the Public Health Act 1991, based on the revised US Centers for Disease Control and Prevention (CDC) case definition2, but excluding individuals with CD4 counts below 200/pl if they do not have an AIDSdefining illness.
Studies have shown improved case reporting when active case finding is used in addition to passive surveillance. More complete AIDS surveillance has also been achieved through laboratory-based reporting of conditions indicative of AIDS. In 1994 the NSW Health Department undertook active case finding for AIDS in several public hospitals and private general practices. This estimated that medical practitioners reported only 82 per cent of AIDS cases4.
Extrapulmonary cryptococcosis is an AIDS-defining illness (ADI) that occurs in 5-10 per cent of patients with AIDS, and is one of the most common opportunistic infections1. Since March 1994 the Centre for Infectious Diseases and Microbiology, Westmead Hospital, Sydney, has been collecting data for the ACSR which aims to provide descriptive epidemiological data on cryptococcal disease in Australia. Information collected by the ACSR includes demographic details, site(s) of infection, underlying condition (including HIV infection), laboratory tests and biotype. All major public (hospital-based) and private laboratories, as well as some hospital infectious diseases physicians, have agreed to participate in the ACSR.
Linking two independent surveillance systems allows the assessment of the completeness of each system5. The aim of this study was to evaluate under-reporting of AIDS cases in NSW by determining the number of people with HTV infection who had cryptococcosis and therefore fulfilled the case definition for AIDS, but were not included on the NSWAR. * Estimated using Chandra Sekar-Deming method a match, cases had to fulfil all three identifiers, including some part of the name code (the NSWAR records the first two letters of the surname and given name). Cases not reported to the NSWAR were investigated by local Public Health Units (PHUs). Referring doctors were urged to complete AIDS notification forms if they had not done so already.
PEOPLE WITH HIV AND CRYPTOCOCCOSIS: COMPARISON OF SURVEILLANCE Y THE AUSTRALIAN CRYPTOCOCCAL SURVEILLANCE REGISTER (ACSR) AND THE NSW AIDS REGISTER (NSWAR)
We used the Chandra Sekar-Deming (CSD) method to compare the completeness of reporting of the ACSR and the NSWAR for cryptococcosis as an ADI5.
RESULTS
During the 18-month study period 57 NSW residents who had Cryptococcus and H[V infections were reported to the ACSR. As of October 31, 1995, 38 (67 per cent) of these had been reported to the NSWAR and 19 (33 per cent) had not. Follow-up of the 19 unreported cases led to 13 cases being reported to the NSWAR with AIDS. Of the six remaining unreported cases, two resided outside NSW, two could not be traced and two are yet to be reported.
During the same period, 56 NSW residents were reported to NSWAR with Ccyptococcus infection as an ADI at the time of initial AIDS diagnosis. Of these 56, 38 (68 per cent) were on the ACSR. Of these 38, 21 had cryptococcosis recorded as an ADI and 17 had another ADI. The remaining 18(32 per cent) were not reported to the ACSR. Table 2 compares the completeness of reporting of the ACSR and the NSWAR. Based on the CSD method, the completeness of reporting of the ACSR was 68 per cent (57/84), and that of the NSWAR was 66 per cent (56/84). The number of potential AIDS cases with cryptococcosis infection that was missed by both systems was estimated to be nine cases, and the combined completeness of the two systems was 89 per cent.
METHOD
The following information was obtained on all NSW residents who had been reported to the ACSR between March 1, 1994 and August 31, 1995, and had HIV infection recorded as an underlying condition: a name code comprising the first letters of the sm-name and given name, date of birth, sex, name and address of doctor requesting detection of Ccyptococcus, and the cryptococcal biotype.
Cases on the ACSR were matehed with those in the NSWAR using the date of birth, name code and sex. To be
DISCUSSION
Cryptococcosis is the most common life-threatening fungal infection in people with AIDS. Of those who develop cryptococcosis, it is the initial ADI in 40-45 per cent5. The epidemiology of cryptococcosis is changing globally, with a documented increase in incidence in western countries.
Since the only way to diagnose cryptococcal disease is through definitive laboratory identification, it lends itself well to a laboratory-based surveillance system. Our study found that linking the ACSR and the NSWAR improved Vol.7/No.6
AIDS surveillance-one-.third of the cases with HIV in the cryptococcal database had not been notified as AIDS cases.
in the past, the main reasons given by doctors for not reporting people with AIDS were difficulties with reporting procedures and the complicated AIDS case definition, concerns about maintaining patient confidentiality and inadequate Health Department feedback on AIDS surveillance data8. However, in this study, the follow-up of non-reported cases was carried out by PFIIJs and we were unable to determine the factors that Ted to non-reporting or delayed reporting.
The CSD method assumes that the two systems compared are independent, that all events (diagnoses) identified are true events, and that all true matches are identified6. The ACSR relies on the voh.mtary reporting of cryptococcal cases by busy physicians and laboratory personnel. Poor reporting practices of infectious diseases by medical practitioners have been well documented9. However, since the end of this study, anecdotal reports suggest that reporting to ACSR by medical practitioners and laboratories has improved, with compliance now approaching 95 per cent. Collation of data for the first 12 months of the ACSR has identified 75 NSW residents with both Cryptococcus and H1V infections.
People with AIDS and cryptococcosis may not be identified to have cryptococcosis on the NSWAIR unless it was the ADI. Cryptococcosis in HIV-positive patients is said to occur when the CD4 lymphocyte count is in the range 75-1251pi, a level lower than that at which other ADIs such as tuberculosis, Kaposi's sarcoma arid lymphoma occur'°.
In our study only two cases could not be identified or matched. This could have been for any number of reasons such as laboratory or clerical error, fictitious reports (if the patient decides to use a pseudonym), or inaccurate data transfer. Some of the non-reported cases may have been reported after October 1995, either with cryptococcosis or some other ADI.
Improving prophylaxis of opportunistic infections in people with advanced HTV disease will lead to shifts in the timing and severity of the occurrence of ADI'. Cryptococcosis may take on more prominence as an ADI when prophylaxis for Pneumocystis carinii pneumonia (PCP) is usedu. On the other hand, the occurrence of cryptococcosis may be delayed or prevented by the use of prophylaxis for candidiasis'2. We believe the ACSR will play a valuable role in monitoring and documenting the changing epidemiology of not only cryptococcal disease in Australia, but in the manifestations of AIDS as well.
Given the high social and economic costs of AIDS, it is important both for epidemiologic studies and resource planning to have as complete and timely surveillance data as possible. Annual linkage of ACSR and the NSWAIR can be done quickly and with relative ease, and would be a valuable contribution to AIDS surveillance.
